USX:NVIV - InVivo Therapeutics Holdings Corp InVivo Therapeutics Holdings C
Sector: Health Care, Industry: Health Care Equipment
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 4.86    +0.03 (+0.62%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

27 May 2022


Loading...
Loading...
Loading...

General

CEO: Dr. Richard M. Toselli

IPO: 2010-10-29

Headquarters: US

Employees: 7

Homepage

Description

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms